glp-1 class action Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Insulin, GLP-1 makers to face

An oral option for type 2 diabetes is also available: oral semaglutide (Rybelsus), which is taken as a daily pill on an empty stomach

Why a Healthy Diet is Key While Taking GLP-1 Agonists GLP-1 agonists help manage Type 2 diabetes and obesity, but are not a magic bullet

To view or add a comment, sign in 1,606 followers

10.1016/j.bbrc.2013.03.010 [DOI] [PubMed] [Google Scholar] 15.Patel BD, Ghate MD

The cardiovascular safety profiles of GLP-1RAs are favorable, with no significant increase in the incidence of acute pancreatitis or pancreatic cancer reported.14 However, their use is associated with a higher frequency of gastrointestinal adverse events, such as nausea, vomiting, and diarrhea.15 GLP-1RAs are considered safe in patients with chronic kidney disease and effective in reducing the risk of severe hypoglycemia.16 In individuals with established cardiovascular diseases, GLP-1RAs have been shown to significantly lower the risk of major adverse cardiovascular events.15 Nevertheless, limited cardiovascular and renal outcome data for certain agents, such as oral semaglutide, have constrained their broader clinical application.17 In the context of post-transplant diabetes, GLP-1RAs exhibit efficacy and safety profiles comparable to those observed in non-transplant populations.18 This review was conducted through comprehensive searches of electronic databases, including Web of Science and PubMed, using a full-text search strategy

Tirzepatide Was a Game Changer I started on Semaglutide and switched to Tirzepatide